Pier Capital »

Day One Biopharmaceuticals I shares owned by Pier Capital

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Pier Capital from 13F filings

Historical chart of Pier Capital investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Pier Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Pier Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 259k 14.60

More positions owned by Pier Capital

Hexcel Corp Common Stocks (HXL)
Evercore Common Stocks (EVR)
Vaxcyte Common Stocks (PCVX)
RayzeBio Common Stocks
Maximus Common Stocks (MMS)
Calix Common Stocks (CALX)
Fabrinet Common Stocks (FN)
Houlihan Lokey Common Stocks (HLI)
Installed Building Products Common Stocks (IBP)
Onespaworld Common Stocks (OSW)
MSA Safety Common Stocks (MSA)
Vertex Common Stocks (VERX)
Ollie s Bargain Outlet Holdings Common Stocks (OLLI)
Applied Industrial Tech Common Stocks (AIT)
Advanced Drainage Systems Common Stocks (WMS)

View all positions for Pier Capital

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Franklin Resources
Braidwell
Viking Global Investors
T. Rowe Price Associates
Goldman Sachs Group
Deerfield Management Company
First Turn Management
Henderson Group
TimesSquare Capital Management
Partner Fund Management
Boxer Capital
Baker Bros. Advisors

View all funds holding Day One Biopharmaceuticals I